Filing Details

Accession Number:
0001601485-21-000091
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-21 16:25:24
Reporting Period:
2021-12-20
Accepted Time:
2021-12-21 16:25:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1601485 Angion Biomedica Corp. ANGN Pharmaceutical Preparations (2834) 113430072
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1640447 F. John Neylan C/O Angion Biomedica Corp.
51 Charles Lindbergh Blvd.
Uniondale NY 11553
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-12-20 358 $2.62 35,136 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The shares reported in this Form 4 were sold pursuant to a 10b5-1 trading plan adopted on March 18, 2021 by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Awards ("RSAs") granted by the Issuer.